论文部分内容阅读
目的:分析欣母沛对于产后子宫出血的临床治疗效果。方法:从2014年5月到2016年5月于我院分娩的孕产妇中选取88例产后子宫出血产妇作为研究对象。根据临床救治方案分成采用缩宫素治疗的对照组(44例)与采用欣母沛治疗的观察组(44例),对两组的临床效果与子宫出血量进行观察与比较。结果:采用欣母沛治疗的观察组中治疗显效者36例,占81.82%,治疗有效者6例,占13.63%,无效2例,占45.45%,总有效率95.45%,子宫出血量为(214.82±16.27)ml。采用缩宫素治疗的对照组中治疗显效者30例,占68.18%,治疗有效者7例,占15.91%,无效7例,占15.91%,总有效率84.09%,子宫出血量为(304.46±13.88)ml。两组治疗有效率及子宫出血量均存在统计学差异,p均<0.05。结论:欣母沛对于产后子宫出血的治疗效果显著,可有效降低子宫出血量,值得推广。
Objective: To analyze the clinical therapeutic effect of Xin-Pei on postpartum uterine bleeding. Methods: From May 2014 to May 2016, 88 maternal women with postpartum uterine bleeding were chosen as pregnant women in our hospital. According to the clinical treatment plan, the patients in the control group (44 cases) treated with oxytocin and the observation group (44 cases) treated with ximinpei were divided into two groups. The clinical effects and the amount of uterine bleeding were observed and compared. Results: In the observation group with Xinmaitai treatment, 36 cases were effective in treatment, accounting for 81.82%, 6 cases were effective in treatment, accounting for 13.63%, 2 cases were ineffective, accounting for 45.45%, the total effective rate was 95.45% and the amount of uterine bleeding was ( 214.82 ± 16.27) ml. In the control group treated with oxytocin, the effective rate was 30 cases (68.18%), effective treatment was 7 cases (15.91%), ineffective in 7 cases (15.91%), total effective rate was 84.09%, uterine bleeding was (304.46 ± 13.88) ml. The two groups of treatment efficiency and uterine bleeding were statistically significant differences, p <0.05. Conclusion: Xin Maopei treatment of postpartum uterine bleeding is significant, can effectively reduce the amount of uterine bleeding, it is worth promoting.